Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ehjcr/62"'
Publikováno v:
European Heart Journal: Case Reports
Background:The worldwide spread of coronavirus disease 2019 (COVID-19) is still not under control and vaccination in Japan started in February 2021, albeit later than in Europe and the USA. The COVID-19 vaccination frequently leads to minor adverse r
Publikováno v:
European Heart Journal: Case Reports
Background Sacubitril/valsartan is approved for the treatment of chronic heart failure with reduced left ventricular ejection fraction of ≤40% to decrease mortality and morbidity. Nasal pruritus is not a recognized adverse effect in the product inf
Autor:
Keyvan Karimi Galougahi
Publikováno v:
European Heart Journal: Case Reports